The first and most common mutation described in mesothelioma is the deletion of the Cyclin D dependent Kinase inhibitor 2A (CDKN2A) gene on chromosome 9 [9], accounting for approximately 70% of MPM cases [10]. This evidence concerns the gene CDKN2A and mesothelioma.